UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )*
XILLIX TECHNOLOGIES CORPORATION
-----------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------
(Title of Class of Securities)
983925-10-8
-----------------------------------------
(CUSIP Number)
December 31, 1998
-----------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed: [ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP NO. 983925-10-8 SCHEDULE 13G
---------------------
(1) NAMES OF REPORTING PERSON S.S.
OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MIRAVANT MEDICAL TECHNOLOGIES 77-0222872
- ---------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- ---------------------------------------------------------------------------
(3) SEC USE ONLY
----------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-----------------------------------------------------------------------
(5) SOLE VOTING POWER
NUMBER OF SHARES 2,691,904 Shares
BENEFICIALLY OWNED -----------------------------------------------------
BY EACH REPORTING
PERSON WITH (6) SHARED VOTING POWER
None
-----------------------------------------------------
(7) SOLE DISPOSITIVE POWER
2,691,904 Shares
-----------------------------------------------------
(8) SHARED DISPOSITIVE POWER
None
-----------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,691,904 Shares
-----------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN
SHARES* [ ]
-----------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9%
-----------------------------------------------------------------
(12) TYPE OF REPORTING PERSON*
CO
-----------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
ITEM 1(a). Name of Issuer:
XILLIX TECHNOLOGIES CORPORATION
ITEM 1(b). Address of Issuer's Principal Executive Offices:
2339 COLUMBIA STREET
VANCOUVER, BC CANADA V6V2V4
ITEM 2(a) Name of Person Filing:
MIRAVANT MEDICAL TECHNOLOGIES
ITEM 2(b) Address of Principal Business Office or, if none, Residence:
7408 HOLLISTER AVENUE
SANTA BARBARA, CA 93117
ITEM 2(c) Citizenship:
ORGANIZED UNDER THE LAWS OF DELAWARE
ITEM 2(d) Title of Class of Securities:
COMMON STOCK
ITEM 2(e) CUSIP Number:
983925-10-8
ITEM 3. If this Statemetn is filed pursuant to Rule 13d-1(b), or 13d-2(b) or
(c), Check whether person filing is:
NOT APPLICABLE
ITEM 4. Ownership
(a) Amount Beneficially Owned: 2,691,904
(b) Percent of Class: 9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 2,691,904
(ii) shared power to vote or to direct the vote: 0
(iii)sole power to dispose or to direct the disposition of: 2,691,904
(iv) shared power to dispose or to direct the disposition of: 0
ITEM 5. Ownership of five percent or less of a class
NOT APPLICABLE
ITEM 6. Ownership of more than five percent on behalf of another person
NOT APPLICABLE
ITEM 7. Identification and classification of the subsidiary which acquired
the security being reported on by the partent holding company
NOT APPLICABLE
ITEM 8. Identification and classification of members of the group
NOT APPLICABLE
ITEM 9. Notice of dissolution of group
NOT APPLICABLE
ITEM 10. Certification
BY SIGNING BELOW, I CERTIFY THAT, TO THE BEST OF MY KNOWLEDGE AND BELIEF, THE
SECURITIES REFERRED TO ABOVE WERE NOT ACQUIRED AND ARE NOT HELD FOR THE PURPOSE
OF OR WITH THE EFFECT OF CHANGING OR INFLUENCING THE CONTROL OF THE ISSUER OF
THE SECURITIES AND WERE NOT ACQUIRED IN CONNECTION WITH OR AS A PARTICIPANT IN
ANY TRANSACTION HAVING THAT PURPOSE OR EFFECT.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
February 25, 1999 MIRAVANT MEDICAL TECHNOLOGIES
/s/ JOHN M. PHILPOTT
--------------------------------------
JOHN M. PHILPOTT
CHIEF FINANCIAL OFFICER
